StockpollyBeta
Get App
Popularity #5,023
HBIO · NASDAQ · Medical - Instruments & Supplies

Harvard Bioscience (HBIO)

Builds research tools for preclinical and cellular-and-molecular science.

$7.92
After-hours close−0.03 (−0.38%)
At close$7.95(−0.63%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue252825232225222021242123
Cost of revenue111310109111010910910
Gross profit151515131314121012141213
161517151514621112121214
Research & development333332222222
121212111110109991010
Selling & marketing666565555555
General & administrative656655544455
Other expenses1022214901101
Operating income−10−2−2−20−50−1020−1
0−1−2−1−31−1−1−1−5−3−2
Interest expense1111111112−22
Other non-operating income−11102−1010350
Income before tax−1−1−4−3−41−51−2−1−3−3−3
Income tax expense110001000000
Net income from continuing operations−1−2−5−3−50−50−2−1−3−3−3
Net income−1−2−5−3−50−50−2−1−3−3−3
EPS, basic−$0.29−$0.43−$1.10−$0.67−$1.10$0.00−$11.40−$0.52−$0.28−$0.64−$0.77−$0.64
EPS, diluted−$0.29−$0.43−$1.10−$0.67−$1.10$0.00−$11.40−$0.52−$0.28−$0.64−$0.77−$0.64
Weighted average shares, basic444444444445
Weighted average shares, diluted444444444445
EBITDA21−2−1−23−48011−41
Depreciation & amortization222222221112
EBIT00−4−3−41−50−10−1−5−1